Scientific Programme 2017
Areas of controversy – Topics for APCCC 2017
- Management of castration-sensitive/naive prostate cancer
- Management of castration-resistant prostate cancer (CRPC): M0 disease management and sequencing/combination treatment for metastatic CRPC
- Use of novel imaging modalities
- Molecular characterization: Tissue and blood based biomarkers in daily clinical practice
- Germline mutations
- Management of high risk and locally advanced prostate cancer
- Oligometastatic and oligo-progressive prostate cancer
- Supportive care and side effects of treatment
- Patient reported outcomes
- Global access to prostate cancer drugs and treatment in countries with limited resources
